Home › Free Stock Grades › TNXP
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Grade
TNXP · Healthcare
C
Market Cap
$157.8M
P/E Ratio
—
Revenue Growth (YoY)
+29.9%
Net Margin
-946.2%
Return on Equity
—
Dividend Yield
None
About Tonix Pharmaceuticals Holding Corp.'s fundamentals
Tonix Pharmaceuticals is a small-cap biotech company with a market capitalization of $157.8 million that reported strong revenue growth of 29.9% year-over-year, indicating expanding sales activity. However, the company is currently unprofitable with a net margin of -946.2% and reported a net loss in its latest annual statement, reflecting the typical cash burn pattern of early-stage pharmaceutical developers. The company does not pay a dividend, which is common for pre-profitability biotech firms that reinvest resources into research and development.